CLINICAL_TRIALS
trial_result
· 2013-05-27
Clinical Trial Update: Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes Mellitus [Phase 3]
Summary
A Phase 3 trial evaluating the efficacy and safety of adding DLBS3233 to standard therapy in patients with Type 2 diabetes mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dexa Medica Group | Conditions: Type-2 Diabetes Mellitus | Phase 3 | Status: COMPLETED